MeSH tree: C15.378.463
Sitting in a recliner in her south Kansas City home, wearing a bright pink sweater, matching lipstick, and with her nails neatly manicured, Shantell Williams recalls the months she spent recovering and rehabbing from the ...
Mar 31, 2025
0
15
A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first myeloma patient with this therapy, resulting in a very good response without severe complications. ...
Mar 27, 2025
0
23
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against ...
Mar 10, 2025
0
41
Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare disease. Of the 7,000 known RD conditions, 80% have a genetic origin, yet over 95% remain incurable. ...
Feb 27, 2025
0
19
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer Institute for Cell Therapy ...
Feb 21, 2025
0
32
Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say researchers from the University of Leeds and The Institute of Cancer Research.
Feb 20, 2025
0
17
The American Cancer Society (ACS) has released Cancer Statistics for African American and Black People, 2025. According to the report, the cancer mortality rate declined from 1991 to 2022 by 49% and 33% in Black men and women, ...
Feb 20, 2025
0
14
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, report researchers from Berlin and Heidelberg in Science Immunology. The detailed ...
Feb 10, 2025
0
48
Brighton and Sussex Medical School and Royal Sussex County Hospital researchers have published an analysis of Francis Hauksbee the Younger's 1743 "Experimentum Crucis." In the analysis, the researchers consider the systematic ...
For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.
Jan 24, 2025
0
17
